BAI fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
BenevolentAI SA is a holding company, which engages in the research and development and sale of AI-enabled drugs. Its business platform combines artificial intelligence and machine learning in discovering medicines. It operates through the UK and Europe geographical segments. The company was founded by Ivan Griffin, Kenneth Patrick Mulvany, and Michael Brennan in November 2013 and is headquartered in London, the United Kingdom.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
BAI does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company